BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 22187159)

  • 1. Genome-wide Runx2 occupancy in prostate cancer cells suggests a role in regulating secretion.
    Little GH; Noushmehr H; Baniwal SK; Berman BP; Coetzee GA; Frenkel B
    Nucleic Acids Res; 2012 Apr; 40(8):3538-47. PubMed ID: 22187159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Runx2 transcriptome of prostate cancer cells: insights into invasiveness and bone metastasis.
    Baniwal SK; Khalid O; Gabet Y; Shah RR; Purcell DJ; Mav D; Kohn-Gabet AE; Shi Y; Coetzee GA; Frenkel B
    Mol Cancer; 2010 Sep; 9():258. PubMed ID: 20863401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-466 inhibits tumor growth and bone metastasis in prostate cancer by direct regulation of osteogenic transcription factor RUNX2.
    Colden M; Dar AA; Saini S; Dahiya PV; Shahryari V; Yamamura S; Tanaka Y; Stein G; Dahiya R; Majid S
    Cell Death Dis; 2017 Jan; 8(1):e2572. PubMed ID: 28125091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FOXO1 inhibits Runx2 transcriptional activity and prostate cancer cell migration and invasion.
    Zhang H; Pan Y; Zheng L; Choe C; Lindgren B; Jensen ED; Westendorf JJ; Cheng L; Huang H
    Cancer Res; 2011 May; 71(9):3257-67. PubMed ID: 21505104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integration of cap analysis of gene expression and chromatin immunoprecipitation analysis on array reveals genome-wide androgen receptor signaling in prostate cancer cells.
    Takayama K; Tsutsumi S; Katayama S; Okayama T; Horie-Inoue K; Ikeda K; Urano T; Kawazu C; Hasegawa A; Ikeo K; Gojyobori T; Ouchi Y; Hayashizaki Y; Aburatani H; Inoue S
    Oncogene; 2011 Feb; 30(5):619-30. PubMed ID: 20890304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis of osteoblast gene expression profiles and Runx2 genomic occupancy of mouse and human osteoblasts in vitro.
    Tarkkonen K; Hieta R; Kytölä V; Nykter M; Kiviranta R
    Gene; 2017 Aug; 626():119-131. PubMed ID: 28502869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RUNX2 overexpression and PTEN haploinsufficiency cooperate to promote CXCR7 expression and cellular trafficking, AKT hyperactivation and prostate tumorigenesis.
    Bai Y; Yang Y; Yan Y; Zhong J; Blee AM; Pan Y; Ma T; Karnes RJ; Jimenez R; Xu W; Huang H
    Theranostics; 2019; 9(12):3459-3475. PubMed ID: 31281490
    [No Abstract]   [Full Text] [Related]  

  • 8. Nitric Oxide Up-Regulates RUNX2 in LNCaP Prostate Tumours: Implications for Tumour Growth In Vitro and In Vivo.
    Nesbitt H; Browne G; O'Donovan KM; Byrne NM; Worthington J; McKeown SR; McKenna DJ
    J Cell Physiol; 2016 Feb; 231(2):473-82. PubMed ID: 26189652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Runx2 phosphorylation in prostate cancer and association with metastatic disease.
    Ge C; Zhao G; Li Y; Li H; Zhao X; Pannone G; Bufo P; Santoro A; Sanguedolce F; Tortorella S; Mattoni M; Papagerakis S; Keller ET; Franceschi RT
    Oncogene; 2016 Jan; 35(3):366-76. PubMed ID: 25867060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of androgen-independent prostate cancer cell aggressiveness by FTY720: validating Runx2 as a potential antimetastatic drug screening platform.
    Chua CW; Chiu YT; Yuen HF; Chan KW; Man K; Wang X; Ling MT; Wong YC
    Clin Cancer Res; 2009 Jul; 15(13):4322-35. PubMed ID: 19509141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Runx2 association with progression of prostate cancer in patients: mechanisms mediating bone osteolysis and osteoblastic metastatic lesions.
    Akech J; Wixted JJ; Bedard K; van der Deen M; Hussain S; Guise TA; van Wijnen AJ; Stein JL; Languino LR; Altieri DC; Pratap J; Keller E; Stein GS; Lian JB
    Oncogene; 2010 Feb; 29(6):811-21. PubMed ID: 19915614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrin αvβ3 and CD44 pathways in metastatic prostate cancer cells support osteoclastogenesis via a Runx2/Smad 5/receptor activator of NF-κB ligand signaling axis.
    Gupta A; Cao W; Chellaiah MA
    Mol Cancer; 2012 Sep; 11():66. PubMed ID: 22966907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Runx2 regulates survivin expression in prostate cancer cells.
    Lim M; Zhong C; Yang S; Bell AM; Cohen MB; Roy-Burman P
    Lab Invest; 2010 Feb; 90(2):222-33. PubMed ID: 19949374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of breast cancer metastasis by Runx2 and estrogen signaling: the role of SNAI2.
    Chimge NO; Baniwal SK; Little GH; Chen YB; Kahn M; Tripathy D; Borok Z; Frenkel B
    Breast Cancer Res; 2011; 13(6):R127. PubMed ID: 22151997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory roles of Runx2 in metastatic tumor and cancer cell interactions with bone.
    Pratap J; Lian JB; Javed A; Barnes GL; van Wijnen AJ; Stein JL; Stein GS
    Cancer Metastasis Rev; 2006 Dec; 25(4):589-600. PubMed ID: 17165130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ets-1 and runx2 regulate transcription of a metastatic gene, osteopontin, in murine colorectal cancer cells.
    Wai PY; Mi Z; Gao C; Guo H; Marroquin C; Kuo PC
    J Biol Chem; 2006 Jul; 281(28):18973-82. PubMed ID: 16670084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis.
    Saini S; Majid S; Yamamura S; Tabatabai L; Suh SO; Shahryari V; Chen Y; Deng G; Tanaka Y; Dahiya R
    Clin Cancer Res; 2011 Aug; 17(16):5287-98. PubMed ID: 21159887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel androgen receptor target genes in prostate cancer.
    Jariwala U; Prescott J; Jia L; Barski A; Pregizer S; Cogan JP; Arasheben A; Tilley WD; Scher HI; Gerald WL; Buchanan G; Coetzee GA; Frenkel B
    Mol Cancer; 2007 Jun; 6():39. PubMed ID: 17553165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recruitment of coregulator G9a by Runx2 for selective enhancement or suppression of transcription.
    Purcell DJ; Khalid O; Ou CY; Little GH; Frenkel B; Baniwal SK; Stallcup MR
    J Cell Biochem; 2012 Jul; 113(7):2406-14. PubMed ID: 22389001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of RUNX2 transcription factor in epithelial mesenchymal transition in non-small cell lung cancer lung cancer: Epigenetic control of the RUNX2 P1 promoter.
    Herreño AM; Ramírez AC; Chaparro VP; Fernandez MJ; Cañas A; Morantes CF; Moreno OM; Brugés RE; Mejía JA; Bustos FJ; Montecino M; Rojas AP
    Tumour Biol; 2019 May; 41(5):1010428319851014. PubMed ID: 31109257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.